TreeHouse Foods (THS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Q4 2024 adjusted net sales reached $911.4 million and adjusted EBITDA was $118.3 million, both in line with expectations, with nearly 4% growth driven by improved volume and mix despite supply chain and recall challenges.
Fiscal year 2024 adjusted net sales were $3.38 billion and adjusted EBITDA was $337 million, reflecting stable performance and margin gains amid a difficult consumer environment.
The company completed the acquisition of Harris Tea in January 2025, enhancing private label tea capabilities and expected to be accretive to net sales and EBITDA.
Voluntary recall of frozen griddle products led to temporary facility closure, with production and shipments resuming in Q1 2025 and minimal expected financial impact.
Executed supply chain and margin management initiatives, driving profitability despite macroeconomic headwinds.
Financial highlights
Q4 2024 adjusted net sales increased 0.2% year-over-year to $911.4 million; adjusted EBITDA rose 9.1% to $118.3 million, with margin improving to 13%.
Fiscal 2024 adjusted net sales were $3.38 billion and adjusted EBITDA was $337 million, both within guidance.
Free cash flow for FY 2024 was $126.1 million, up from $16.5 million in 2023.
Q4 gross profit margin improved to 19.5% from 16.7% a year ago, driven by supply chain savings and insurance recovery.
Q4 operating expenses fell by $13.3 million year-over-year, reflecting lower incentive compensation and reduced severance and freight costs.
Outlook and guidance
Fiscal 2025 adjusted net sales are expected between $3.34 billion and $3.4 billion, flat at the midpoint, with volume and mix expected to decline ~1% year-over-year.
Adjusted EBITDA for 2025 is expected in the range of $345–$375 million; free cash flow projected at least $130 million.
Q1 2025 adjusted net sales are expected at $785–$800 million (down ~3.5% year-over-year), and adjusted EBITDA at $38–$46 million.
Capital expenditures for 2025 are projected at $125 million, with a multi-year glide path to lower CapEx rates.
Latest events from TreeHouse Foods
- Q2 sales and EBITDA beat guidance, but net loss driven by impairment; H2 growth expected.THS
Q2 20242 Feb 2026 - Merger and related proposals approved, paving way for new ownership structure.THS
EGM 20262 Feb 2026 - Private label growth, cost savings, and a strong pipeline set the stage for margin expansion in 2024-25.THS
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Operational improvements and private label focus drive growth and stronger financial outlook.THS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Stockholders will vote on a merger with Investindustrial, offering $22.50 per share plus a CVR.THS
Proxy Filing20 Jan 2026 - Product recall and weak demand cut sales, but margin gains drove 14% EBITDA growth.THS
Q3 202414 Jan 2026 - Operational focus and portfolio optimization support stable growth amid a challenging market.THS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Shareholders to vote on a cash-and-CVR merger, with board and key investors supporting approval.THS
Proxy Filing29 Dec 2025 - Shareholders to vote on a $22.50-per-share cash merger and CVR, with board unanimous support.THS
Proxy Filing17 Dec 2025